EMPRISE Trademark

Trademark Overview

On Thursday, December 21, 2017, a trademark application was filed for EMPRISE with the United States Patent and Trademark Office. The USPTO has given the EMPRISE trademark a serial number of 79229786. The federal status of this trademark filing is REGISTERED as of Tuesday, January 29, 2019. This trademark is owned by Boehringer Ingelheim International GmbH. The EMPRISE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research in the field of diabetes, cardiovascular diseases, chronic kidney disease and epidemiological studies; providing medical and scientific research information in the field of pharmaceuticals and clinical trials

General Information

Serial Number79229786
Word MarkEMPRISE
Filing DateThursday, December 21, 2017
Status700 - REGISTERED
Status DateTuesday, January 29, 2019
Registration Number5663596
Registration DateTuesday, January 29, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 13, 2018

Trademark Statements

Goods and ServicesMedical and scientific research in the field of diabetes, cardiovascular diseases, chronic kidney disease and epidemiological studies; providing medical and scientific research information in the field of pharmaceuticals and clinical trials

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, April 6, 2018
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBoehringer Ingelheim International GmbH
Party Type30 - Original Registrant
Legal Entity Type27 - NOT AVAILABLE
AddressDE
Party NameBoehringer Ingelheim International GmbH
Party Type20 - Owner at Publication
Legal Entity Type27 - NOT AVAILABLE
AddressDE
Party NameBoehringer Ingelheim International GmbH
Party Type10 - Original Applicant
Legal Entity Type27 - NOT AVAILABLE
AddressDE

Trademark Events

Event DateEvent Description
Monday, January 29, 2024COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, June 14, 2019FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, May 24, 2019FINAL DISPOSITION NOTICE SENT TO IB
Thursday, May 23, 2019FINAL DISPOSITION PROCESSED
Monday, April 29, 2019FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, January 29, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, November 13, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 13, 2018PUBLISHED FOR OPPOSITION
Friday, November 9, 2018NOTIFICATION PROCESSED BY IB
Wednesday, October 24, 2018NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, October 24, 2018NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, October 24, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, September 26, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 25, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 25, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 25, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, April 28, 2018REFUSAL PROCESSED BY IB
Thursday, April 12, 2018NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, April 12, 2018REFUSAL PROCESSED BY MPU
Tuesday, April 10, 2018NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, April 10, 2018APPLICATION FILING RECEIPT MAILED
Monday, April 9, 2018NON-FINAL ACTION WRITTEN
Friday, April 6, 2018ASSIGNED TO EXAMINER
Friday, April 6, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 5, 2018SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

emprise medical field research scientific providing information trials studies clinical pharmaceuticals